Board of Directors
Company Risk
In the event that a manufacturer is required to cease production for the Company for any reason, particularly for popular products with high sales volumes, this could impact the Company's business continuity and may significantly affect the Company's operating performance.
To manage and diversify the risks associated with having a limited number of manufacturers, the Company has initiated the selection of additional manufacturers in both South Korea and Thailand. This aims to increase the diversity of both domestic and international production sources and to mitigate potential risks arising from raw material shortages. Furthermore, different manufacturers possess varying expertise in product innovation across different categories. Only manufacturers with international production standards, stability, and business sustainability will be selected. For key products with high sales proportions and popularity, the Company has arranged for the sourcing and development of additional manufacturers alongside the primary ones, ensuring that quality improvements are made to be equivalent to or superior to existing manufacturers.
In the event of imitation of such products, it could impact the company's operational performance and have a negative effect on both financial results and the company's reputation.
- The Company enters into agreements with all manufacturers who are aware of its product formulations, requiring them to agree not to disclose or disseminate the production formulas, product ingredients, or manufacturing processes to others. They also agree not to produce and sell products sold by the Company themselves, either in the country of manufacture or for export to other countries, with this agreement remaining in effect for 1-3 years after the Company ceases placing orders with that manufacturer. - The Company registers trademarks for its products where legally permissible, covering both Thailand and international markets where it plans to enter or expand. This also includes registering patents for the Company's products, both domestically and internationally, to prevent and reduce the risk of imitation of the Company's trademarks and new innovations. - The Company allocates marketing budgets to build brand recognition and loyalty, foster trust, and encourage the purchase of genuine products. It communicates with consumers to choose products from reliable distribution channels, such as the Company's authorized dealers, department stores and leading retailers that are partners with the Company, and leading e-marketplace authorized dealers appointed by the Company, among others. - The Company consistently invests significant capital or dedicates substantial time to research and develop innovative products that are difficult to imitate, in order to enhance its competitive advantage and help reduce the risk of product imitation.
The challenge for the beauty product market industry is the necessity to utilize new technologies to enhance products and services, as well as to create brand distinctiveness to meet consumer demands and suit consumers in each segment. This has resulted in significantly increased competition within this industry and an abundance of competitors in the market.
The Company recognizes this risk and has therefore established guidelines for management and for creating competitive opportunities and business success for the Company as follows: - The Company's marketing strategy continues to prioritize offering "skincare products that utilize "innovative" key ingredients within the cosmetics and beauty industry," which has always been the Company's strength. This involves introducing new technologies to meet consumer demands, maintaining efficient and safe product manufacturing standards, while keeping prices accessible so that consumers can easily perceive and decide to purchase the products, in line with the Company's objectives, all while maintaining profit margins at the Company's projected levels. - Building product identity and brand recognition (Brand Awareness) through continuous marketing investment to increase awareness and reinforce consumers' recognition and memory of the Company's products, trademarks, patents, and the distinctive characteristics and qualities of all its products. This is achieved by adjusting communication strategies, promotional activities, or public relations plans across various media, both off-line, such as television advertisements to promote new products and famous Brand Ambassadors to keep the brand in the Top of Mind of consumers and compete with other brands in the skincare and beauty product market, and online, such as product reviews by KOLs/KOCs and the use of social media platforms like Facebook, TikTok, IG, and Twitter to reach target groups who currently use these types of media. - Accessing consumers through diverse and comprehensive distribution channels, primarily selecting those that are reliable and widely accepted by consumers. The advantage of having diverse, easily accessible, and convenient distribution channels contributes to consumers' ease of decision-making and purchase. Currently, the Company's products are available both off-line in various retail formats, including beauty and health product stores such as Watsons and Eveandboy, and convenience stores, which now, in addition to 7-Eleven, also include CJ, a rapidly expanding chain. Online e-Commerce channels include Shopee, Lazada, and TikTok.
If the company is unable to effectively assess and respond to evolving consumer needs and behaviors in a timely manner, its opportunities for success will be diminished.
The Company therefore places great importance on understanding consumer needs and behaviors, mandating annual assessments of consumer demands for both skincare and cosmetic products, both domestically and internationally. These assessments are conducted using both qualitative methods (Qualitatively), such as interviewing various consumer groups (Focus Group Discussion) and analyzing international popularity trends, and quantitative methods (Quantitatively), such as reviewing market data and conducting market research (Consumer Survey). These insights are utilized for marketing planning, developing existing products, and designing new products, thereby ensuring that the Company's products effectively and rapidly align with evolving consumer behaviors. This approach is considered the core objective and essence of the Company's operations.
The Company recognizes the risk of relying primarily on convenience store channels and such customers, and to mitigate such risks
- The company has a contingency plan for risk management by introducing new products for sale in other Modern Trade channels, such as Big C, Lotus. - Adjusting the e-commerce channel plan by organizing Live Streaming distribution, utilizing influencers, as well as KOL/KOC for product reviews and affiliate marketing, to enable consumers to make purchases conveniently from digital platforms. resulting in the company having sales distributed through e-commerce - Expanding distribution to international markets is another distribution channel that the company expects will complement and generate growth for the company. The markets included in the company's plan are Vietnam, Laos, Cambodia, and Myanmar, before expanding to other key markets in Southeast Asia during 2025-2030, according to the established business development plan.
The Company has recognized this risk, which negatively impacts the brand image of Rojukiss.
The company therefore continues to operate cautiously and adheres to the working principles that have been continuously practiced for over 19 years, which include strict adherence to manufacturing standards and product quality testing by experts (Dermatologically Tested) to alleviate customer concerns and ensure the company's strong confidence in product quality and safety. To reduce reliance solely on facial skincare products, the company has further building on the brand's success with a variety of products, such as the brand's popular facial masks. a wide selection of Rojukiss products, including Korean-style lip care sticks that help address issues such as chapped lips, dry lips, colorless lips, and dark lips, among others. Additionally, the company plans to diversify risk by strengthening other brands. In 2025, the company launched a new look for its Sis2Sis product line (cosmetic products in sachets with built-in brushes) into the market.
The company may face risks from new products not being accepted or favored by consumers, particularly in a highly competitive business environment with numerous new products being launched by competitors in the market.
Therefore, the company systematically reviews its new product development plans to mitigate the risk of failure in launching new products, as follows: - The Product Development Department is responsible for the systematic development of new products, including design, testing, and selection of new products to meet the needs of target groups. This involves working closely with manufacturers in South Korea to study beauty industry trends and plan product launches that align with business opportunity analysis and marketing strategies, which will be handled by the Marketing Department. - Establish a procedure for the Product Development Department and Marketing Department to propose plans for approval from the Management and Sales Departments, to collaboratively select and provide feedback on new products to be distributed both domestically and internationally, including the appropriate size and packaging characteristics for distribution in each channel. Present new product plans to key partners to gather feedback and assess the feasibility of launching products. Monitor the success rate to utilize successes/risks in refining marketing plans to ensure that defined sales targets can be achieved. - The Product Development Department and the Purchasing Department jointly select suitable manufacturers, who may be domestic or from South Korea, based on past performance, quality, and agreed-upon prices. Before accepting products, the Product Development Department will randomly sample products for inspection prior to confirming their acceptance into the warehouse. - The Marketing Department is responsible for conducting research, analyzing consumer behavior, planning product introductions to the market, advertising and public relations, and organizing marketing activities to drive awareness and trial purchases of new products among target customers, as well as repeat purchases, to ensure a satisfactory success rate for new product investments. This also includes adjusting plans as appropriate if consumer response trends do not meet expectations, and mitigating investment risks for new product launches. - There is a dedicated person responsible for coordinating with FDA (Food and Drug Administration) officials, who possesses knowledge and understanding of compliance with rules and prohibitions. Regulatory procedures must be followed and approval obtained from relevant agencies. Only then will the Purchasing Department instruct the manufacturer to commence production.
This may result in the risk of inventory impairment in the event that the popularity or demand for such products changes.
the Company deems it necessary to plan in advance to ensure sufficient inventory levels for marketing plans and to consistently cover all distribution channels comprehensively. In 2023, 2024, and 2025. The Company maintains an average inventory level equivalent to 125 days, 126 days, and 119 days. In order to mitigate such risks, Furthermore, the Company mandates a review of inventory storage and the establishment of policies for managing safety stock appropriate to each product type, including consistently managing products according to their shelf life. For instance, if products have a short remaining shelf life or inventory movement is slow due to decreased consumer demand, sales promotion campaigns will be considered to accelerate product sales. Additionally, regular reviews are conducted to control and reduce quantities, as well as to cease further production orders and discontinue sales for certain items that generate low sales or are prone to obsolescence.
have a significant negative impact on the company's image and trademark.
The Company endeavors to limit consumer dissatisfaction to a narrow scope and to resolve such damages as quickly as possible. The Company has established the following action plan: - Quality Control The Company prioritizes product quality, implementing quality control procedures from formula development, production, pre-storage inspection, and transportation to the point of sale to customers. Every production lot of products will have a quality certificate from the manufacturer to ensure that the products sold will satisfy customers with their quality and safety when purchased and used. - Product Liability insurance The Company selects manufacturing facilities that carry Product Liability insurance for producing goods for the Company. This is to cover cases where lawsuits are filed and it is proven that consumers have suffered damage from using the product due to ingredients, raw materials used, or manufacturing processes that do not meet established standards. The insurance company and the manufacturer will be responsible for such damages. - Team to handle product complaints Establish a team to handle product complaints across all distribution channels, covering issues such as quality, packaging, or damaged goods (provided it can be proven that the damage originated from the Company). This will be done within a defined timeframe to prevent customers from feeling that the Company is neglecting or evading responsibility. Customers must provide necessary information in accordance with the Company's product complaint policy. The responsible party will respond to customers within 24 hours to update on progress and proceed with approval and dispatch of replacement products to customers within 3-7 days. However, this complaint process does not cover consumer satisfaction derived from product use or allergic reactions. In cases of product allergies, consumers must follow the procedures established by the Company to genuinely prove an allergic reaction from using the Company's products (e.g., a medical certificate from a reputable medical institution). This is to ensure a fair and accurate conclusion for both the Company and the consumers. - Compensated and mitigated In 2025, there were an average of no more than 10 complaints per month from consumers regarding dissatisfaction with quality, packaging, or damaged goods. The Company has already compensated and mitigated consumer dissatisfaction within the specified timeframe.
may lead to risks arising from the inability to fully comply with the terms of licenses, requirements, or various orders from relevant government agencies, which could result in the relevant regulatory government agencies considering the suspension or revocation of licenses, and/or incurring legal liability for the company. Alternatively, risks from non-compliance with laws and regulations could cause operational disruption, necessitating a halt in operations or incurring costs to manage potential impacts.
To mitigate this risk and to comply with laws and regulations correctly, as a responsible business operator, the Company proceeds as follows: 1. Appoint a responsible person to study and monitor changes in relevant laws and regulations, and to act as an auditor, guiding relevant departments to operate in accordance with laws and regulations pertaining to product claims and advertising of properties, such as the Product Development Department, Product/Packaging Design Department, and Marketing Department, to ensure that personnel at all levels operate within the framework of relevant laws and regulations, thereby reducing errors and the risk of fines, cancellations, suspension of sales, or product recalls. 2. The Company will consider engaging external legal counsel (if necessary) when complex legal issues are identified and the existing team may lack sufficient understanding. The engagement of external legal counsel will undoubtedly enable the Company to mitigate such risks.
The Company has invested in foreign subsidiaries that operate in their respective local currencies, which consequently creates a risk of foreign exchange loss if the Thai Baht depreciates.
The Company has managed risks by entering into forward foreign exchange contracts (Forward Contract) to mitigate the risk arising from exchange rate fluctuations to an appropriate extent.
which results in data breaches, business disruptions, and reputational damage
To maintain cybersecurity under the guidance of Internal & External Audit through Endpoint Security. The company restricts the use of external devices for connection to company equipment, such as USBs and external hard drives. Such devices must be registered in the system to allow connection only to registered endpoints, thereby preventing the introduction of viruses or malware that may be embedded in other files unrelated to work. This was implemented in Q2/2024, and other annual activities continue to be carried out to reduce risks to operating systems and cyber threats, such as - The IT department organizes training for employees to review operational procedures for both office and warehouse staff, in cases where employees suspect they have received phishing mail or malware, including how to observe email messages and links that may lead to ransomware. This also includes an annual update on cyber invasion situations for current employees. New employees will receive Cyber Security training on their first day of work. This is to ensure that employees understand and are aware of cyber threats that could cause business damage to the company. - Annual data recovery testing according to the business continuity plan, to ensure that backed-up data is up-to-date and that in case of an emergency, data can be restored within the specified timeframe. - Management provides sufficient budget support for the procurement of modern anti-virus software with the capability to protect against operating system attacks and cyber threats.
Given that it is a new law, there may be an inadequate understanding of its provisions, which could potentially lead to errors.
The company is well aware of this risk and has received recommendations from the internal audit committee, which evaluated the operational plan regarding this matter. This is due to significant amendments still required for legal compliance. Therefore, the plan for complying with personal data protection laws should be made more stringent, including: - Recruit a Data Protection Officer (who will coordinate and monitor the use of personal data by all departments within the company to comply with the Personal Data Protection Act B.E. 2562. The officer should be someone who has undergone training and received a certificate related to the Personal Data Protection Act, in order to provide clear practical guidelines to relevant departments, work more effectively in accordance with the said law, and have independence in monitoring and supervising the company's use of personal data, replacing the appointment of representatives from each department to oversee themselves). - A centralized record of personal data usage must be established and updated in real-time to enable verification of who accessed personal data, when, and whether it was for the specified purposes. - Enhance the complete workflow for departments that use data, covering data collection objectives, consent requests, recording of personal data usage, and destruction of collected data within the specified timeframe.
If the Company is unable to retain its management team and employees with knowledge, capabilities, and positive attitudes, or is unable to recruit replacement personnel within an appropriate timeframe, this may significantly and negatively impact the Company's business operations, operating results, and financial position.
To mitigate such risks, the Company has prepared personnel in each field to be able to support the work of senior executives. This includes recruiting professional personnel to assist in management, developing succession plans for key positions, specifically for all Chief Officer level personnel. Key successors are selected and appointed with the approval of the Nomination and Remuneration Committee, and the Nomination and Remuneration Committee directly recruits the Chief Executive Officer. The Company regularly reviews and monitors the progress of these succession development plans, as well as initiating the fostering of relationships between middle management and operational staff to maintain good relationships among future generations of executives. The plans for retaining talented employees who are crucial mechanisms in the Company's business operations are as follows: - The Company has established a standard for employee compensation management, utilizing data from sources such as Korn Ferry, Manpower, and Adecco. An annual comparison of employee compensation is conducted and presented to the Nomination and Remuneration Committee to ensure that the Company allocates appropriate remuneration to executives and employees commensurate with their responsibilities and that it is competitive with leading organizations in the same or similar industries. - Project for the issuance and offering of warrants to purchase shares of the Company to executives and employees (ESOP Warrant) as follows: (1) At the Extraordinary General Meeting of Shareholders No. 1 held on July 14, 2020, a resolution was passed to approve the project for the issuance and offering of warrants to purchase shares of the Company to executives and employees (ESOP Warrant) for the first time, totaling not exceeding 18 million shares, with a par value of 0.5 Baht per share, representing not more than 2.9 percent of the Company's paid-up capital after such offering. This is to incentivize and retain personnel within the Company. Employees will be able to gradually exercise their rights to purchase the Company's ordinary shares at a price of 7.20 Baht, with an exercise ratio of 1 warrant per 1 ordinary share. The rights can be gradually exercised upon completion of 24 months from the warrant issuance date, which was the date the Company first issued and offered ordinary shares to the public on February 19, 2021, until the expiration of the 60-month period. (2) At the Annual General Meeting of Shareholders 2025 held on April 24, 2025, a resolution was passed to approve the project for the issuance and offering of warrants to purchase shares of the Company to executives and employees (ESOP Warrant) for the second time, totaling not exceeding 48 million shares, with a par value of 0.5 Baht per share, representing not more than 7.41 percent of the Company's paid-up capital after such offering. This is to incentivize and retain personnel within the Company. Employees will be able to gradually exercise their rights to purchase the Company's ordinary shares at a price of 4.30 Baht, with an exercise ratio of 1 warrant per 1 ordinary share. The rights can be gradually exercised upon completion of 24 months from the warrant issuance date until the expiration of the 60-month period.
Shareholder Risk
Such shareholding proportion results in AAH being the major shareholder and having controlling power over the company, and being able to veto special resolutions of the shareholders' meeting which require a three-fourths vote of the shareholders present and entitled to vote. Consequently, other shareholders of the company face the risk of not being able to gather sufficient votes to counterbalance matters proposed by AAH for consideration by the shareholders' meeting.
However, the Company's management structure stipulates a total of 5 committees, each with clearly defined scopes of authority and responsibilities, ensuring transparency in the Company's management and a verifiable system. - Board of Directors - Audit Committee - Nomination and Remuneration Committee - Good Corporate Governance, Risk Management, and Sustainability Committee - Executive Committee The Board of Directors comprises a total of 9 members, including 6 independent directors, with an additional 3 independent directors serving as members of the Audit Committee. Their role is to audit, balance decision-making, and consider the approval of various transactions before presenting them to the shareholders' meeting. In cases where connected transactions are entered into with directors, major shareholders, controlling persons, related entities, including individuals who may have conflicts of interest, such individuals shall not have the right to vote on the approval of such transactions. Furthermore, in cases of securities offerings that affect shareholders, minority shareholders have the right to object by using only 10 percent of the votes of shareholders attending the meeting. Additionally, the approval of transactions must comply with the criteria of the Securities and Exchange Commission ("SEC") and the Stock Exchange of Thailand ("SET").
Companies in which Private Equity funds invest may create conflicts of interest with other shareholders of the company, or may invest in businesses that are synergistic with the company's operations. This could result in the company being deprived of investment opportunities in such businesses, thereby hindering its ability to enhance its performance for the ultimate benefit of the company or its other shareholders.
On July 21, 2020, AAH confirmed in writing (Confirmation Letter) to the Company that it would not invest in businesses that compete with the Company in the same market (considering the characteristics, price, or intended use of the goods or services) throughout the period that AAH remains a major shareholder of the Company. Should it be proven that damage is incurred by the Company or its shareholders due to AAH intentionally investing in a business that competes with the Company in the same market, according to the criteria specified in the Confirmation Letter, while AAH is a major shareholder of the Company, AAH shall compensate the Company or its shareholders for such damages as prescribed by law.
The Company may face risks if it is unable to appropriately adjust its organizational structure for management, or if it cannot procure suitable and sufficient personnel in a timely manner to support its growing operations. This could adversely affect the Company's business operations, operating results, financial position, and reputation.
The company prioritizes improving human resource management approaches to ensure employees possess skills and abilities aligned with business directions. - Recruit knowledgeable, capable, creative personnel who can adapt to the company's rapidly changing business environment, for example, by hiring Mid-Career employees with skills and expertise who can contribute their valuable work skills and further develop the potential of their subordinates more effectively. - Develop employee development plans in line with changes, with each departmental head overseeing employee development closely to ensure that the company retains skilled and specialized personnel in their roles, allowing the business to operate smoothly and efficiently on an ongoing basis.
The sale of such shares to the company's executives and employees may impact the trading price of the company's shares. It is not possible to predict the extent of any negative impact (if any) that future share sales or the holding of shares for future sale may have on the company's stock price on the stock exchange. Nevertheless, offering warrants to purchase the company's shares to executives and employees serves as an incentive to enhance performance efficiency, which will ultimately generate maximum benefit for the company and its shareholders, in addition to retaining knowledgeable personnel.
If there is a significant sale of the Company's shares on the stock exchange, it may negatively impact the Company's share price on the stock exchange and could lead to the Company encountering difficulties in raising capital through the stock exchange at a price and time that the Company deems appropriate.
Following the initial public offering (IPO), the agreement between the shareholders of AAH and Ms. Piyawadee Sonsingh, and the agreement between AAH and Guts & Good shall become effective. Ms. Piyawadee and Guts & Good have entered into an agreement with AAH not to offer, sell, dispose of, or otherwise transfer shares of the Company, except for the sale of shares by Ms. Piyawadee and Guts & Good in the initial public offering (IPO) as agreed by the contracting parties. Furthermore, as long as AAH remains a major shareholder of the Company, Ms. Piyawadee and Guts & Good agree not to sell or transfer any shares to any other person without the consent of AAH. Any sale or transfer of shares by shareholders must comply with the securities and exchange law, and the sale or disposal of shares held by each contracting party must be in proportion to their respective shareholding.
Such offering may result in certain groups of investors not being entitled to participate in the company's future rights offering to existing shareholders proportionally, and this may lead to a dilution of the shareholding proportion of such existing shareholders.
The Company has no obligation and does not expect to register its securities in any secondary market other than the Stock Exchange of Thailand, to allow foreign investors to subscribe for shares offered to the Company's existing shareholders on a pro-rata basis (Rights Offering) when the Company proceeds with a future share offering.
Unlock full benchmarking
Claim this company to see every KPI your sector qualifies for, from 70+ across the market, benchmarked against sector peers.

